Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Aging Cell 16(4):815-817
Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage Induced by IschemiaReperfusion Injury in Rats
A study published in NCBI [3], administration of GHK-Cu in an in vivo wound chamber model produced a dose-dependent increase in total protein, collagen content, and glycosaminoglycan accumulation relative to untreated controls
FDA Regulatory Status The FDAs position is unambiguous: BPC-157 is not an approved drug for any medical condition
Once reconstituted, solutions should be used promptly per the research protocol
5-Oxoprolinase deficiency Disease name 5-Oxoprolinase deficiency (OMIM 260005) Definition and diagnostic criteria 5-Oxoprolinase deficiency is a very rare autosomal recessive disease characterized by 5-oxoprolinuria and very heterogeneous clinical presentation (renal stone formation, enterocolitis, mental retardation, neonatal hypoglycemia, microcytic anemia and microcephaly)
